Pharmaceutical Executive June 29, 2022
As director of corporate strategy for Novartis, Anastasiia Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.
Pharm Exec: How have recent events, including COVID-19, impacted your strategies?
Kamenska: We approach development of strategy from both short- to mid- as well as long-term perspectives. Strategic planning for the long-term view typically requires taking into consideration inherent uncertainty of the market’s performance and complexity of industry dynamics. The scale of change and disruption that we have observed in the last few years has served as a great reminder of the importance of assessing multiple scenarios, including those seemingly with only limited likelihood of occurrence. We strive to be...
Today's Sponsors
Today's Sponsor